Consumer Health in Australia
Australia reopened its borders in the first quarter of 2022 along with a relaxing of various restrictions. Thus, the country witnessed a greater resumption of normality, including the return to the workplace and more frequent socialising after two years of snap lockdowns. This has led to higher incidence of viruses such as influenza and other respiratory illnesses, supporting further demand for various consumer health products including cough, cold and allergy (hay fever) remedies, analgesics, m...
Euromonitor International's Consumer Health in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
- Consumer Health in Australia
- Euromonitor International
- November 2022
- List Of Contents And Tables
- CONSUMER HEALTH IN AUSTRALIA
- EXECUTIVE SUMMARY
- Consumer health in 2022: The big picture
- 2022 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
- Table 2 Life Expectancy at Birth 2017-2022
- MARKET DATA
- Table 3 Sales of Consumer Health by Category: Value 2017-2022
- Table 4 Sales of Consumer Health by Category: % Value Growth 2017-2022
- Table 5 NBO Company Shares of Consumer Health: % Value 2018-2022
- Table 6 LBN Brand Shares of Consumer Health: % Value 2019-2022
- Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2017-2022
- Table 8 Distribution of Consumer Health by Format: % Value 2017-2022
- Table 9 Distribution of Consumer Health by Format and Category: % Value 2022
- Table 10 Forecast Sales of Consumer Health by Category: Value 2022-2027
- Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
- APPENDIX
- OTC registration and classification
- Vitamins and dietary supplements registration and classification
- Self-medication/self-care and preventive medicine
- Switches
- Summary 1 OTC: Switches 2021-2022
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 2 Research Sources
- ANALGESICS IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Rise in common colds and illnesses post-pandemic leads to further demand for analgesics in Australia
- Panic buying continues to place pressure on supply chain of analgesics
- Reckitt Benckiser (Australia) Pty Ltd launches next generation of Nurofen with Nurofen Meltlets
- PROSPECTS AND OPPORTUNITIES
- Growth rates to gradually normalise over forecast period but demand will remain high despite rising unit prices
- Associated harmful side effects could trigger more conservative use of analgesics
- Chronic pain expected to rise over the forecast period contributing to sales of analgesics
- CATEGORY DATA
- Table 12 Sales of Analgesics by Category: Value 2017-2022
- Table 13 Sales of Analgesics by Category: % Value Growth 2017-2022
- Table 14 NBO Company Shares of Analgesics: % Value 2018-2022
- Table 15 LBN Brand Shares of Analgesics: % Value 2019-2022
- Table 16 Forecast Sales of Analgesics by Category: Value 2022-2027
- Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2022-2027
- COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Strong demand for combination products - cough, cold and allergy (hay fever) remedies due to surge in influenza cases
- Free vaccine rollout to ramp up influenza vaccination rates
- Johnson & Johnson strengthens leadership of cough, cold and allergy (hay fever) remedies in 2022
- PROSPECTS AND OPPORTUNITIES
- New product development expected to drive sales of cough, cold and allergy (hay fever) remedies
- Stable demand for antihistamines/allergy remedies in line with greater mobility and climate change
- CATEGORY DATA
- Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2017-2022
- Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2017-2022
- Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2022
- Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2019-2022
- Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2022-2027
- Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2022-2027
- DIGESTIVE REMEDIES IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Effects of COVID-19 help drive demand for diarrhoeal remedies
- Unhealthy eating habits fuel growth of laxatives
- Johnson & Johnson strengthens leadership of digestive remedies with wide product portfolio
- PROSPECTS AND OPPORTUNITIES
- Ageing demographic contributes to demand for digestive remedies
- Threat of substitutes and healthier lifestyles can hinder stronger growth for digestive remedies
- Slower rate of decline for H2 blockers but Australians now rely on alternatives
- CATEGORY DATA
- Table 24 Sales of Digestive Remedies by Category: Value 2017-2022
- Table 25 Sales of Digestive Remedies by Category: % Value Growth 2017-2022
- Table 26 NBO Company Shares of Digestive Remedies: % Value 2018-2022
- Table 27 LBN Brand Shares of Digestive Remedies: % Value 2019-2022
- Table 28 Forecast Sales of Digestive Remedies by Category: Value 2022-2027
- Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2022-2027
- DERMATOLOGICALS IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Higher stress levels and greater mobility drive demand for dermatologicals in 2022
- Nappy (diaper) rash treatments benefits from temporary rise in birth rate during pandemic
- Dermatologicals remains highly fragmented competitive landscape in Australia
- PROSPECTS AND OPPORTUNITIES
- Self-care and personal health and wellness trends expected to positively shape dermatologicals positively over the forecast period
- Ageing population another contributing factor to growth of dermatologicals
- CATEGORY DATA
- Table 30 Sales of Dermatologicals by Category: Value 2017-2022
- Table 31 Sales of Dermatologicals by Category: % Value Growth 2017-2022
- Table 32 NBO Company Shares of Dermatologicals: % Value 2018-2022
- Table 33 LBN Brand Shares of Dermatologicals: % Value 2019-2022
- Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2019-2022
- Table 35 Forecast Sales of Dermatologicals by Category: Value 2022-2027
- Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2022-2027
- NRT SMOKING CESSATION AIDS IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Health and wellness trends underpin growth of NRT smoking cessation
- Extensive product range of major players with specific benefits contribute to demand
- Brands of NRT smoking cessation aids tap into younger adult audience by utilising digital strategies
- PROSPECTS AND OPPORTUNITIES
- Limited growth for NRT smoking cessation aids due to decline in smoking population over the forecast period
- NRT smoking cessation aids expected to see greater competition from alternative options
- CATEGORY INDICATORS
- Table 37 Number of Smokers by Gender 2017-2022
- CATEGORY DATA
- Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2017-2022
- Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2017-2022
- Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2018-2022
- Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2019-2022
- Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2022-2027
- Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2022-2027
- SLEEP AIDS IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Growth boosted by the return to busier lifestyles amongst local population
- Growth in wellness-driven demand contributes to sales
- Switch of melatonin boosts demand from ageing population
- PROSPECTS AND OPPORTUNITIES
- Slower growth expected due to growing competition from natural options and alternative services
- New product development and innovation will strengthen consumer interest
- Ageing population expected to support growth of sleep aids in Australia
- CATEGORY DATA
- Table 44 Sales of Sleep Aids: Value 2017-2022
- Table 45 Sales of Sleep Aids: % Value Growth 2017-2022
- Table 46 NBO Company Shares of Sleep Aids: % Value 2018-2022
- Table 47 LBN Brand Shares of Sleep Aids: % Value 2019-2022
- Table 48 Forecast Sales of Sleep Aids: Value 2022-2027
- Table 49 Forecast Sales of Sleep Aids: % Value Growth 2022-2027
- EYE CARE IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Ongoing use of digital devices positively drives demand for eye care
- Demand for allergy eye care continues to rise as consumers spend greater time outdoors
- Eye care remains consolidated competitive landscape
- PROSPECTS AND OPPORTUNITIES
- Climate change impacts allergens and allergic diseases, lifting demand for allergy eye care
- Players expected to offer specific value to consumers through technology and social media
- E-commerce expected to gain further growth momentum, despite dominance of store-based retailing over the forecast period
- CATEGORY DATA
- Table 50 Sales of Eye Care by Category: Value 2017-2022
- Table 51 Sales of Eye Care by Category: % Value Growth 2017-2022
- Table 52 NBO Company Shares of Eye Care: % Value 2018-2022
- Table 53 LBN Brand Shares of Eye Care: % Value 2019-2022
- Table 54 Forecast Sales of Eye Care by Category: Value 2022-2027
- Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2022-2027
- WOUND CARE IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Growth underpinned by consumers returning to organised group sports and outdoor activities
- Product innovation biggest driver of category growth in 2022
- Johnson & Johnson Pacific and Beiersdorf Australia retain strength with new line extensions
- PROSPECTS AND OPPORTUNITIES
- Ageing population and ongoing participation in sports will contribute to further demand for wound care
- Innovation expected to be limited due to highly mature and competitive category
- Embracing social media to reach a broader target audience and gain relevance over the forecast period
- CATEGORY DATA
- Table 56 Sales of Wound Care by Category: Value 2017-2022
- Table 57 Sales of Wound Care by Category: % Value Growth 2017-2022
- Table 58 NBO Company Shares of Wound Care: % Value 2018-2022
- Table 59 LBN Brand Shares of Wound Care: % Value 2019-2022
- Table 60 Forecast Sales of Wound Care by Category: Value 2022-2027
- Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2022-2027
- VITAMINS IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Multivitamins significantly outperforms single format due to rising cost concerns
- Players look to format innovation to add interest
- Increasing competition from practitioner-only vitamins
- PROSPECTS AND OPPORTUNITIES
- Stabilising of demand, but marketing likely to be hindered by new regulation
- Further opportunities for personalisation and subscription services
- Growing competition from functional wellness
- CATEGORY DATA
- Table 62 Sales of Vitamins by Category: Value 2017-2022
- Table 63 Sales of Vitamins by Category: % Value Growth 2017-2022
- Table 64 Sales of Multivitamins by Positioning: % Value 2017-2022
- Table 65 NBO Company Shares of Vitamins: % Value 2018-2022
- Table 66 LBN Brand Shares of Vitamins: % Value 2019-2022
- Table 67 Forecast Sales of Vitamins by Category: Value 2022-2027
- Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2022-2027
- DIETARY SUPPLEMENTS IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Immunity support and a focus on indigenous ingredients help drive further growth of dietary supplements in 2022
- Increasingly diverse approach to health offers both opportunities and competition
- New regulations likely to hinder marketing efforts
- PROSPECTS AND OPPORTUNITIES
- Greater demand for sustainable products and packaging offers opportunities
- Dietary supplements with beauty positioning set to gain further momentum
- Increasing competition from functional/fortified foods
- CATEGORY DATA
- Table 69 Sales of Dietary Supplements by Category: Value 2017-2022
- Table 70 Sales of Dietary Supplements by Category: % Value Growth 2017-2022
- Table 71 Sales of Dietary Supplements by Positioning: % Value 2017-2022
- Table 72 NBO Company Shares of Dietary Supplements: % Value 2018-2022
- Table 73 LBN Brand Shares of Dietary Supplements: % Value 2019-2022
- Table 74 Forecast Sales of Dietary Supplements by Category: Value 2022-2027
- Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2022-2027
- WEIGHT MANAGEMENT AND WELLBEING IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Further declines in 2022, while supplement nutrition drinks benefits from expanding target audience
- Weight management faces strong competition from sports nutrition
- Smaller players gain share from leaders, while brands in supplement nutrition drinks fare better
- PROSPECTS AND OPPORTUNITIES
- Weak performance overall as Australians take a more holistic approach to weight control
- Rising obesity to support stable demand for OTC obesity
- Social media promotion of weight management likely to be impacted by new regulation
- CATEGORY DATA
- Table 76 Sales of Weight Management and Wellbeing by Category: Value 2017-2022
- Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2017-2022
- Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2018-2022
- Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2019-2022
- Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2022-2027
- Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2022-2027
- SPORTS NUTRITION IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Expansion further blurs the line between sports nutrition and functional foods
- Intensifying competition in fragmented landscape with private label looking to expand its presence
- E-commerce continues to gain share within sports nutrition with wide product offer and competitive prices
- PROSPECTS AND OPPORTUNITIES
- Lines to continue blurring between sports nutrition and functional foods
- Rising prices and supply chain disruption could slow growth, but overall demand will continue to rise
- Sports nutrition to increasingly push boundaries
- CATEGORY DATA
- Table 82 Sales of Sports Nutrition by Category: Value 2017-2022
- Table 83 Sales of Sports Nutrition by Category: % Value Growth 2017-2022
- Table 84 NBO Company Shares of Sports Nutrition: % Value 2018-2022
- Table 85 LBN Brand Shares of Sports Nutrition: % Value 2019-2022
- Table 86 Forecast Sales of Sports Nutrition by Category: Value 2022-2027
- Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2022-2027
- HERBAL/TRADITIONAL PRODUCTS IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Shift towards a more positive consumer perception of herbal/traditional products drives sales
- E-commerce gains further ground in 2022 but remains small distribution channel
- New product development within herbal/traditional cough, cold and allergy (hay fever) remedies supports value growth
- PROSPECTS AND OPPORTUNITIES
- New ingredients in herbal/traditional products gaining in popularity
- Younger demographics to boost demand for sustainable herbal/traditional products
- New product development within skin care expected to positively influence herbal/traditional dermatologicals
- CATEGORY DATA
- Table 88 Sales of Herbal/Traditional Products by Category: Value 2017-2022
- Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2017-2022
- Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2018-2022
- Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2019-2022
- Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2022-2027
- Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2022-2027
- PAEDIATRIC CONSUMER HEALTH IN AUSTRALIA
- KEY DATA FINDINGS
- 2022 DEVELOPMENTS
- Demand for paediatric cough, cold and allergy remedies supported by strong return of influenza season in Australia
- Paediatric consumer health boosted by ongoing stockpiling trends
- Product innovation within paediatric cough, cold and allergy remedies drives value growth
- PROSPECTS AND OPPORTUNITIES
- Declining birth rates and low fertility expected to slow value growth of paediatric consumer health
- Innovation is key to encouraging demand for paediatric consumer health
- Threat of substitution from natural and holistic children’s remedies
- CATEGORY DATA
- Table 94 Sales of Paediatric Consumer Health by Category: Value 2017-2022
- Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
- Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
- Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2018-2022
- Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2019-2022
- Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
- Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027